Clinical Market Potential in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Clinical Market Potential in Brazil

Clinical Market Potential in Brazil – Full Service CRO

Nestled in South America and boasting a diverse cultural heritage, Brazil is a country known for its vibrant energy and captivating landscapes. Beyond its natural wonders, Brazil’s healthcare sector is experiencing a significant transformation, paving the way for unprecedented clinical market potential.

In this blog, we will delve into the factors driving the growth of the clinical market in Brazil, the current state of its healthcare landscape, and the vast opportunities that lie ahead for investors and healthcare providers willing to embark on this transformative journey.

Healthcare Landscape in Brazil:

Brazil’s healthcare system is a dynamic mix of public and private providers, aiming to serve its vast population of over 210 million people. While the Sistema Único de Saúde (SUS), the country’s public healthcare system, faces challenges in meeting the demands of its citizens, the private healthcare sector has been steadily growing and gaining prominence.

This coexistence of public and private systems creates a unique environment for investors and healthcare entrepreneurs to tap into Brazil’s vast clinical market potential.

Growing Middle-Class and Health Awareness:

As Brazil’s middle class continues to expand, there is a notable increase in disposable income, leading to higher healthcare spending. The growing middle-class segment is also becoming increasingly health-conscious, seeking better medical services and innovative treatments. This trend has spurred the demand for private healthcare, including specialized clinics, advanced medical technologies, and state-of-the-art hospitals, creating a thriving clinical market in the country.

Medical Tourism and Global Appeal:

Brazil’s reputation as a global healthcare destination is gaining momentum, attracting medical tourists from various corners of the world. With its highly qualified medical professionals, cutting-edge facilities, and affordable medical treatments, Brazil has become a sought-after choice for international patients seeking quality healthcare at competitive prices.

The influx of medical tourists has opened up new avenues for investment and collaboration, further bolstering the clinical market potential.

Focus on Research and Innovation:

Brazil is emerging as a frontrunner in medical research and innovation in Latin America. The country’s scientific community is actively engaged in groundbreaking research across various medical fields, including genetics, biotechnology, and pharmaceuticals. The combination of research prowess and a large pool of skilled healthcare professionals positions Brazil as a hub for innovative clinical solutions and cutting-edge treatments.

Clinical Market Potential in Brazil

Clinical Market Potential in Brazil

Clinical Market Potential in Brazil

Telemedicine and Digital Health Revolution:

The digital health revolution is gaining traction in Brazil, particularly with the widespread adoption of telemedicine. Telemedicine solutions are helping to bridge the gap between urban and remote areas, providing healthcare access to underserved populations. Additionally, mobile health apps and remote monitoring technologies are transforming patient care and management, making Brazil an exciting market for digital health investors.

Government Initiatives and Reforms:

The Brazilian government has been proactive in implementing reforms to address healthcare challenges and improve healthcare outcomes. Various initiatives, including increased funding for healthcare infrastructure and insurance expansion programs, are contributing to a more robust healthcare ecosystem. Moreover, regulatory changes are streamlining the process for healthcare startups and encouraging investments in the clinical sector.

Challenges and Opportunities:

Despite its immense potential, the clinical market in Brazil faces challenges that demand attention. Health inequalities between different regions, bureaucratic hurdles, and limited access to specialized care in remote areas are some of the key challenges that need to be addressed. However, these challenges also present opportunities for stakeholders to collaborate, innovate, and develop solutions that cater to the unique needs of Brazil’s diverse population.


Brazil’s clinical market potential is a compelling prospect for investors, entrepreneurs, and healthcare providers worldwide. The country’s mix of public and private healthcare systems, a growing middle class, and its reputation as a global healthcare destination position Brazil as a thriving hub for healthcare innovation and investment.

With a focus on research, embracing telemedicine and digital health, and with the support of government initiatives, Brazil’s healthcare sector is poised for exponential growth. By tapping into this potential and addressing the challenges, stakeholders have the chance to be part of a transformative journey that not only shapes the future of healthcare in Brazil but also contributes to the betterment of global healthcare as a whole.

Clinical Market Potential in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Clinical Market Potential in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Clinical Market Potential in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Clinical Market Potential in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Clinical Market Potential in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Clinical Market Potential in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Clinical Market Potential in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Clinical Market Potential in Brazil

The Cohortias Team

Clinical Market Potential in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Clinical Market Potential in Brazil

Network & Partnerships